These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21431694)

  • 21. Determinants of interferon-stimulated gene induction by RNAi vectors.
    Pebernard S; Iggo RD
    Differentiation; 2004 Mar; 72(2-3):103-11. PubMed ID: 15066190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx].
    Kim JW; Lee SH; Park YS; Jeong SH; Kim N; Lee DH
    Korean J Hepatol; 2009 Mar; 15(1):15-24. PubMed ID: 19346782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective inhibition of Japanese encephalitis virus replication by small interfering RNAs targeting the NS5 gene.
    Qi WB; Hua RH; Yan LP; Tong GZ; Zhang GH; Ren T; Wu DL; Liao M
    Virus Res; 2008 Mar; 132(1-2):145-51. PubMed ID: 18190994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable suppression of gene expression in murine embryonic stem cells by RNAi directed from DNA vector-based short hairpin RNA.
    Tang FC; Meng GL; Yang HB; Li CJ; Shi Y; Ding MX; Shang KG; Zhang B; Xue YF
    Stem Cells; 2004; 22(1):93-9. PubMed ID: 14688395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Construction and in vitro antiviral activity of highly effective artificial miRNA targeting to HIV-1 pol].
    Cheng T; Zhang T; Zhang Y; Wei L; Xia D; Wang Y; Zhang J; Xia N
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):63-73. PubMed ID: 20353094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Construction and identification of RNA interference lentiviral expression vector of galectin-3 gene].
    Wang MD; Shi YF; Wang H; Ma WB; Wang RZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1264-7. PubMed ID: 18676279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective inhibition of infectious bursal disease virus replication in vitro by DNA vector-based RNA interference.
    Gao Y; Liu W; Gao H; Qi X; Lin H; Wang X; Shen R
    Antiviral Res; 2008 Aug; 79(2):87-94. PubMed ID: 18378010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of apoptosis in the liver by systemic and local delivery of small-interfering RNAs.
    Zender L; Kubicka S
    Methods Mol Biol; 2007; 361():217-26. PubMed ID: 17172714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication.
    Westerhout EM; Vink M; Haasnoot PC; Das AT; Berkhout B
    Mol Ther; 2006 Aug; 14(2):268-75. PubMed ID: 16697708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1-specific RNA interference.
    Boden D; Pusch O; Ramratnam B
    Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
    Li MJ; Rossi JJ
    Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and cloning of lentiviral vectors expressing small interfering RNAs.
    Tiscornia G; Singer O; Verma IM
    Nat Protoc; 2006; 1(1):234-40. PubMed ID: 17406238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA.
    Ren XR; Zhou LJ; Luo GB; Lin B; Xu A
    J Viral Hepat; 2005 May; 12(3):236-42. PubMed ID: 15850463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
    Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
    Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
    Li MJ; Kim J; Li S; Zaia J; Yee JK; Anderson J; Akkina R; Rossi JJ
    Mol Ther; 2005 Nov; 12(5):900-9. PubMed ID: 16115802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable lentiviral vector-mediated gene silencing in human monocytic cell lines.
    Lee JS; Reiner NE
    Methods Mol Biol; 2009; 531():287-300. PubMed ID: 19347324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
    Moore MD; McGarvey MJ; Russell RA; Cullen BR; McClure MO
    J Gene Med; 2005 Jul; 7(7):918-25. PubMed ID: 15756649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of knockdown rats by lentiviral transduction of embryos with short hairpin RNA transgenes.
    Dann CT; Garbers DL
    Methods Mol Biol; 2008; 450():193-209. PubMed ID: 18370061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells.
    Li M; Rossi JJ
    Methods Mol Biol; 2005; 309():261-72. PubMed ID: 15990406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.